Search results for " pharmacy."

showing 10 items of 356 documents

Louis Jacques Thenard's Chemistry Courses at the Collège de France, 1804–1835

2010

This article is concerned with the public courses and lecture demonstrations given by Louis Jacques Thenard at the College de France during the first decades of the nineteenth century. The expectations and needs of Thenard's auditors will be studied in order to understand the role played by chemistry courses at the College in the context of the growing and changing Parisian teaching market during the first third of the nineteenth century. The preparation and performance of lecture demonstrations was the main driving force of several major changes in the premises and the personnel associated with the chair of chemistry. Our analysis of the parallel process of expansion and functional differe…

LiteratureParisUniversitiesbusiness.industryTeachingPhilosophyHistory 19th CenturyContext (language use)Parallel processManagementChemistryHistory and Philosophy of ScienceChemistry (miscellaneous)History of PharmacyMedical Laboratory PersonnelHumansCurriculumChemistry (relationship)businessOrder (virtue)Ambix
researchProduct

The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver disease

2020

© 2020 The Author(s).

Liver CirrhosisPROGNOSISCirrhosisSCORING SYSTEM[SDV]Life Sciences [q-bio]PROGRESSIONDiseaseBiomarker Cirrhosis NAFLD NASHSTEATOHEPATITISDEFINITIONSCohort Studies0302 clinical medicineNon-alcoholic Fatty Liver DiseaseNonalcoholic fatty liver diseasePharmacology (medical)030212 general & internal medicineLongitudinal StudiesRegistriesComputingMilieux_MISCELLANEOUSmedia_commonPharmacology. TherapyFatty liverLiver NeoplasmsNASHGeneral Medicine3. Good healthCirrhosisLiver317 PharmacyCohort0305 other medical scienceCohort studymedicine.medical_specialtySettore MED/12 - GASTROENTEROLOGIAGeriatrikQUESTIONNAIRENAFLD; NASH; Cirrhosis; Biomarker610 Medicine & health03 medical and health sciencesNAFLDmedicineSTEATOSISmedia_common.cataloged_instanceHumansALGORITHMEuropean unionIntensive care medicine030505 public healthbusiness.industryCONSUMPTIONBiomarkerSTAGING SYSTEMmedicine.diseaseDiabetes Mellitus Type 2Geriatrics3121 General medicine internal medicine and other clinical medicine3111 BiomedicineHuman medicineSteatohepatitisbusinessBiomarker; Cirrhosis; NAFLD; NASH
researchProduct

Emerging drugs for the treatment of vitiligo.

2020

Introduction: Vitiligo is a relatively common autoimmune depigmenting disorder of the skin. There has been a great advance in understanding the pathological basis, which has led to the development and utilization of various new molecules in treating vitiligo. This review aims at a comprehensively describing the treatments available and the emerging treatment aspects and the scope for future developments.Areas covered: This study comprehensively summarizes the current concepts in the pathogenesis of vitiligo with special focus on the cytokine and signaling pathways, which are the targets for newer drugs. JAK kinase signaling pathways and the cytokines involved are the focus of vitiligo treat…

MAP Kinase Signaling SystemAdministration TopicalVitiligoAdministration OralVitiligoBiologicsBioinformatics030226 pharmacology & pharmacy03 medical and health scienceschemistry.chemical_compound0302 clinical medicineClinical Trials Phase II as TopicLocalized vitiligoMedicineHumansJanus Kinase InhibitorsPharmacology (medical)skin and connective tissue diseasesRandomized Controlled Trials as TopicPharmacologytreatmentintegumentary systembusiness.industrymedicine.diseaseCombined Modality TherapyJAK inhibitorchemistryClinical Trials Phase III as Topic030220 oncology & carcinogenesisCytokinesAfamelanotideDermatologic AgentsbusinessJanus kinaseBiologics; JAK inhibitor; treatment; vitiligoExpert opinion on emerging drugs
researchProduct

Multiple actions of fenamates and other nonsteroidal anti-inflammatory drugs on GABAA receptors

2019

The nonsteroidal anti-inflammatory drug (NSAID) niflumic acid, a fenamate in structure, has many molecular targets, one of them being specific subtypes of the main inhibitory ligand-gated anion channel, the GABA(A) receptor. Here, we report on the effects of other fenamates and other classes of NSAIDs on brain picrotoxinin-sensitive GABA A receptors, using an autoradiographic assay with [S-35]TBPS as a ligand on mouse brain sections. We found that the other fenamates studied (flufenamic acid, meclofenamic acid, mefenamic acid and tolfenamic acid) affected the autoradiographic signal at low micromolar concentrations in a facilitatory-like allosteric fashion, i.e., without having affinity to …

MECHANISM0301 basic medicineNSAID drugsMefenamic acidAllosteric regulationPharmacologyBINDING-SITESGABA03 medical and health sciences0302 clinical medicineTolfenamic acidNiflumic acidmedicineSHIFTMODULATIONReceptorXenopus oocytesAGENTPharmacologyChemistryGABAA receptorNiflumic acidANION GRADIENTA RECEPTORSSUBUNITS3. Good healthMeclofenamic acidFenamates030104 developmental biologyFlufenamic acid317 PharmacyACIDAutoradiography030217 neurology & neurosurgeryRecombinant GABA(A) receptorsRESPONSESmedicine.drugEuropean Journal of Pharmacology
researchProduct

Dissolution behavior of co-amorphous amino acid-indomethacin mixtures: The ability of amino acids to stabilize the supersaturated state of indomethac…

2017

Article

Magnetic Resonance SpectroscopyArgininesupersaturationIndomethacinCo-amorphousbiorelevantPharmaceutical ScienceExcipientPhenylalanine02 engineering and technologyPrecipitationprecipitation030226 pharmacology & pharmacy03 medical and health sciences0302 clinical medicineco-amorphousSpectroscopy Fourier Transform InfraredmedicineAmino AcidsSolubilityDissolutionta116Chromatography High Pressure LiquidSupersaturationChromatographyAqueous solutionCalorimetry Differential ScanningChemistryAnti-Inflammatory Agents Non-SteroidalTryptophanGeneral Medicine021001 nanoscience & nanotechnologyAmino acidSupersaturationSolubilityBiorelevant0210 nano-technologyPowder Diffractionamino acidBiotechnologymedicine.drug
researchProduct

Both cholestatic and steatotic drugs trigger extensive alterations in the mRNA level of biliary transporters in rat hepatocytes: Application to devel…

2016

Disruption of the vectorial bile acid transport in the liver is a key feature of cholestatic drugs, although many causal and mechanistic aspects are still unknown. The aim of the present study was to explore if cholestatic drugs can repress or induce the expression of hepatic transporters. To this end, sandwich-cultured rat hepatocytes were treated with cholestatic and non-cholestatic (steatotic, non-hepatotoxic, etc.) drugs and the mRNA expression of 10 uptake and efflux biliary transporters was measured. Results evidenced that all cholestatic drugs cause extensive alterations in the mRNA expression of most biliary transporters. Surprisingly, nearly all steatotic drugs also affected the ex…

Male0301 basic medicinePathologymedicine.medical_specialtyDrug-Related Side Effects and Adverse ReactionsDrug Evaluation PreclinicalOrganic Anion Transporters Sodium-IndependentPharmacologyBiologyToxicology030226 pharmacology & pharmacyRats Sprague-Dawley03 medical and health sciences0302 clinical medicineCholestasisPredictive Value of TestsIn vivomedicineAnimalsBileRNA MessengerCells CulturedCholestasisMultidrug resistance-associated protein 2Fatty liverTransporterGeneral Medicinemedicine.diseaseRatsFatty Liver030104 developmental biologyTetracyclinesHepatocytesBiomarker (medicine)EffluxSteatosisCarrier ProteinsBiomarkersToxicology Letters
researchProduct

In vitro assessment of competitive and time-dependent inhibition of the nevirapine metabolism by nortriptyline in rats

2018

Abstract Nevirapine (NVP) is a non-nucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1 (HIV-1) widely used as a component of High Active Antiretroviral Therapy (HAART) since it is inexpensive, readily absorbed after oral administration and non-teratogenic. In the present work, the mechanism of a previously described pharmacokinetic interaction between NVP and the antidepressant drug nortriptyline (NT) was studied using rat hepatic microsomes. The obtained results showed a competitive inhibition of the NVP metabolism by NT. The three main NVP metabolites (2-OH-NVP, 3-OH-NVP and 12-OH-NVP) where competitively inhibited with similar inhibitory constant values (Ki …

Male0301 basic medicineTime FactorsMetabolite030106 microbiologyNortriptylineAntidepressive Agents TricyclicPharmacologyBinding Competitive030226 pharmacology & pharmacyBiochemistry03 medical and health scienceschemistry.chemical_compound0302 clinical medicineNon-competitive inhibitionimmune system diseasesOral administrationIn vivomedicineAnimalsNevirapineRats WistarPharmacologyReverse-transcriptase inhibitorChemistryvirus diseasesRatsMicrosomes LiverMicrosomeReverse Transcriptase InhibitorsNortriptylineDrug metabolismmedicine.drugBiochemical Pharmacology
researchProduct

Smart copolymer coated SPIONs for colon cancer chemotherapy

2019

Human colon cancer is one of the higher aggressive solid tumors, whose high mortality, much like many other solid tumors, results from metastasis formation. To reduce this high mortality, more effective chemotherapy, allowing a specific tumor accumulation and an efficient early-stage medical imaging as well, are still needed. At this regard, stimuli-responsive nanocarriers for anticancer drug delivery are promising strategy in cancer therapy. For this purpose, a dual targeted redox-responsive drug delivery system, prepared by coating superparamagnetic nanoparticles (SPIONs) with the amphiphilic copolymer INU-LA-PEG-FA and loading doxorubicin (DOXO-SPIONs) was investigated as tool for solid …

Male3003Colorectal cancerPolymersmedicine.medical_treatmentPharmaceutical ScienceMice Nude02 engineering and technologyDual targeting030226 pharmacology & pharmacyPolyethylene Glycols03 medical and health scienceschemistry.chemical_compoundMice0302 clinical medicineDrug Delivery SystemsFolic AcidmedicineAnimalsHumansDoxorubicinReceptorMagnetite NanoparticlesRedox-responsiveChemotherapyAntibiotics Antineoplasticmedicine.diagnostic_testThioctic AcidInulinSPIONMagnetic resonance imaging021001 nanoscience & nanotechnologymedicine.diseaseMagnetic Resonance ImagingXenograft Model Antitumor AssaysUp-RegulationLipoic acidchemistryDoxorubicinSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoDrug deliveryColonic NeoplasmsCancer researchCancer chemotherapyNanocarriers0210 nano-technologyOxidation-Reductionmedicine.drugMRI
researchProduct

Dissolution and dissolution/permeation experiments for predicting systemic exposure following oral administration of the BCS class II drug clarithrom…

2017

In order to save time and resources in early drug development, in vitro methods that correctly predict the formulation effect on oral drug absorption are necessary. The aim of this study was to 1) evaluate various BCS class II drug formulations with in vitro methods and in vivo in order to 2) determine which in vitro method best correlates with the in vivo results. Clarithromycin served as model compound in formulations with different particle sizes and content of excipients. The performed in vitro experiments were dissolution and dissolution/permeation experiments across two types of membrane, Caco-2 cells and excised rat intestinal sheets. The in vivo study was performed in rats. The oral…

MaleCell Membrane PermeabilityChemistry PharmaceuticalAdministration OralPharmaceutical ScienceExcipient02 engineering and technologyAbsorption (skin)030226 pharmacology & pharmacyExcipients03 medical and health sciences0302 clinical medicineIn vivoClarithromycinmedicineAnimalsHumansIntestinal MucosaRats WistarSolubilityDissolutionChromatographyChemistryPermeation021001 nanoscience & nanotechnologyRatsMucusIntestinal AbsorptionSolubilityPoloxamer 407Caco-2 Cells0210 nano-technologyEx vivomedicine.drugEuropean Journal of Pharmaceutical Sciences
researchProduct

Acetazolamide treatment for infantile central sleep apnea.

2001

Central sleep apnea is a common respiratory pattern in healthy neonates. Nevertheless, frequent central sleep apnea associated with drops in oxygen saturation may contribute to infantile morbidity. Recently, low-dose acetazolamide was shown to reduce symptomatic central sleep apnea in adults. We treated 12 infants, median conceptional age 42 weeks (range, 40-44 weeks), with central sleep apnea. In all cases, the central apnea index was >40/h total sleeping time (apnea ≥ 3 sec). The cumulative duration of drops in oxygen saturation below 90% was more than 3 min/h total sleeping time. All individuals received acetazolamide 7 mg/kg/day (orally, divided in three doses) for 11 weeks. Polysomn…

MaleCentral sleep apneaPolysomnographyPolysomnography030226 pharmacology & pharmacyDrug Administration ScheduleHypoxemia03 medical and health sciences0302 clinical medicineSleep Apnea SyndromesmedicineHumansOximetryRespiratory systemCarbonic Anhydrase InhibitorsOxygen saturation (medicine)medicine.diagnostic_testbusiness.industry05 social sciencesInfant Newborn050301 educationSleep apneaApneamedicine.diseaseAcetazolamideAnesthesiaPediatrics Perinatology and Child HealthFemaleNeurology (clinical)medicine.symptombusinessAcetazolamide0503 educationmedicine.drugJournal of child neurology
researchProduct